Latest News for SOBI.ST
/PRNewswire/ -- Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study (NCT06694701), evaluating Gamifant (emapalumab) in
/PRNewswire/ -- Sobi (STO: SOBI) today hosts its Capital Markets Day, where senior management will provide an update on the company's strategy and outline its
/PRNewswire/ -- Sobi (STO: SOBI) today hosts its Capital Markets Day, where senior management will provide an update on the company's strategy and outline its
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the fourth quarter and full year of 2025. Fourth Quarter 2025 Total
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the fourth quarter and full year of 2025. Fourth Quarter 2025 Total
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SOBI.ST.
Senate Trading
No Senate trades found for SOBI.ST.
U.S. House Trading
No House trades found for SOBI.ST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.